Oncolytics shareholders OK continuance to BC and domestication to Nevada

ONCOLYTICS BIOTECH INC

Continuance from Alberta to British Columbia approved: 85.21% in favor.
Domestication from British Columbia to Nevada approved: 86.98% in favor.
2026 Incentive Award Plan approved (76.77% in favor), conditional on completion of continuance and domestication.
Company expects to complete continuance and domestication by end of Q1 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.